Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort studyYuliya Lytvyn, Jensen Yeung, Asfandyar Mufti et al.|JAAD International|2021Cited by 4
Real-world effectiveness and safety of risankizumab in adult patients with plaque psoriasis: A 1-year international multicenter retrospective cohort studyAhmed Bagit, Jensen Yeung, Khalad Maliyar et al.|Journal of the American Academy of Dermatology|2024Cited by 2
Effectiveness and safety of risankizumab dose optimization in adult patients with plaque psoriasis: An international multicentre retrospective cohort studyAhmed Bagit, Jensen Yeung, Khalad Maliyar et al.|Journal of the European Academy of Dermatology and Venereology|2024Cited by 2
Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort StudyAhmed Bagit, Jensen Yeung, Khalad Maliyar et al.|Journal of Cutaneous Medicine and Surgery|2024Cited by 0